Inventor · Saint-Julien-en-Genevois, FR

Nathalie Corvaia

16Patents
6h-index
14Co-inventors
59Inventor score

Filing activity: Mar 15, 2000 → Jan 18, 2013

Most-cited inventions

PatentTitleAreaCited byStatus
US7241444B2 Anti-IGF-IR antibodies and uses thereof Emerging Cross-Sectional Technologies 54 Expired
US7309494B2 Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine Emerging Cross-Sectional Technologies 11 Expired
US7553485B2 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Chemistry; Metallurgy 9 Expired
US8361461B2 Anti-IGF-IR antibodies and uses thereof Chemistry; Metallurgy 8 Active
US8071730B2 Anti-JAM-A antibodies Chemistry; Metallurgy 7 Active
US8124079B2 Anti-IGF-IR antibodies and uses thereof Human Necessities 7 Active
US8344112B2 IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders Physics 6 Active
US7854930B2 Anti-igf-ir antibodies and uses thereof Human Necessities 5 Active
US7914784B2 Anti-IGF-IR antibodies and uses thereof Emerging Cross-Sectional Technologies 4 Active
US8101180B2 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Chemistry; Metallurgy 2 Active
US7524627B2 Method of generating and/or increasing an immune response against RSV Emerging Cross-Sectional Technologies 1 Active
US8168410B2 Anti-IGF-IR antibodies and uses thereof Emerging Cross-Sectional Technologies 1 Active
US8945871B2 Anti-IGF-IR antibodies and uses thereof Chemistry; Metallurgy 0 Active
US8420085B2 Anti-IGF-IR antibodies and uses thereof Human Necessities 0 Active
US7033591B1 Immunostimulant bacterial membrane fractions in cancer treatment Human Necessities 0 Expired
US8808999B2 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.